HORMONE DEPENDENCE OF MAMMARY-TUMORS INDUCED IN RATS BY INTRAPERITONEAL NMU INJECTION

Citation
G. Martin et al., HORMONE DEPENDENCE OF MAMMARY-TUMORS INDUCED IN RATS BY INTRAPERITONEAL NMU INJECTION, Cancer investigation, 15(1), 1997, pp. 8-17
Citations number
52
Categorie Soggetti
Oncology
Journal title
ISSN journal
07357907
Volume
15
Issue
1
Year of publication
1997
Pages
8 - 17
Database
ISI
SICI code
0735-7907(1997)15:1<8:HDOMII>2.0.ZU;2-T
Abstract
The purpose of this work was to determine the hormone dependence of ma mmary tumors induced in Sprague-Dawley rats by three intraperitoneal i njections of N-nitroso-N-methylurea at 50, 80, and 110 days of age. Tw o experimental designs were carried out: (a) Ten days before the first NMU injection, 130 rats were divided into 13 batches and randomly ass igned to the following treatments: control, ovariectomy (OVX), tamoxif en (TAM), bromocriptine (BROM), haloperidol (HAL), estradiol (E(2)), p rogesterone (Pg), OVX + BROM, TAM + BROM, OVX + HAL, TAM + HAL, OVX TAM, and E(2) + BROM. After 150 days off treatment the following growt h parameters were determined: latency period (LP), mean tumor number p er rat (n/t) and tumor incidence (TI). LP was significantly increased (p < 0.05) only by Pg and TAM + BROM. The n/t was significantly decrea sed (p < 0.05) by all treatments except HAL. TI was significantly redu ced by OVX, TAM, BROM, and their combinations. (b) Rats bearing ip-NMU -induced mammary tumors were divided into 7 batches and assigned to th e following treatments: control, OVX, TAM, BROM, HAL, OVX + BROM, and TAM + BROM. Tumor growth was assessed up to 60 days of treatment; only OVX, TAM and their combination with BROM were able to produce tumor r egression. These results support the essential role of E(2) and prolac tin in the promotion stage of carcinogenesis. However, for established tumors, growth becomes more independent from hormone influence, in pa rticular from prolactin deprivation. We conclude that this model seems suitable for studying the mechanisms under-lying the evasion of hormo nal control of tumor growth.